Literature DB >> 21686405

Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child.

Maria Francesca Messina1, Mariella Valenzise, Salvatore Aversa, Teresa Arrigo, Filippo De Luca.   

Abstract

A boy aged 7.6 years presented to our Unit of Paediatric Endocrinology for evaluation of obesity. Progressive weight gain (10 kg) started 6 months earlier after an accidental penetrating orbital injury on the right eye. During this period the child has been treated with oral betamethasone (0.5 mg/day) for 1 month and dexamethasone 2% ocular drops (2 hourly by day) for 6 months. Physical examination showed he was 113.5 cm in height (-1.5 SD), weight 36.0 kg, blood pressure 110/90 mmHg (90th centile), body mass index 28 (+5 SD), truncal obesity, buffalo hump, "moon-face", increased lanugo hair and supraclavicular fullness. Endocrinological work-up revealed undetectable levels of basal adrenocorticotropic hormone (ACTH), basal and ACTH-stimulated cortisol and 24 h urine excretion cortisol, confirming the diagnosis of iatrogenic Cushing syndrome. The abrupt withdrawal of ocular glucocorticoids by the parents evoked two adrenal crises; 4 months later the patient recovered. In conclusion, we would alert doctors that every formulation of glucocorticoids, no ocular drops excluded, can determine severe systemic side effects and iatrogenic Cushing syndrome.

Entities:  

Year:  2009        PMID: 21686405      PMCID: PMC3027520          DOI: 10.1136/bcr.11.2008.1224

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Cushing's syndrome induced by betamethasone nose drops. Children taking intranasal corticosteroids should be monitored for growth retardation.

Authors:  S Malozowski; M Purucker; A Worobec
Journal:  BMJ       Date:  1999-05-15

Review 2.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Cushing's syndrome induced by betamethasone nose drops. In rhinological disease betamethasone should be regarded as systemic corticosteroid.

Authors:  J J Homer; T G Gazis
Journal:  BMJ       Date:  1999-05-15

Review 4.  Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action.

Authors:  Frank Buttgereit; Rainer H Straub; Martin Wehling; Gerd-Rüdiger Burmester
Journal:  Arthritis Rheum       Date:  2004-11

Review 5.  Drug insight: selective agonists and antagonists of the glucocorticoid receptor.

Authors:  Andrew McMaster; David W Ray
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02

Review 6.  Recent developments in the discovery of selective glucocorticoid receptor modulators (SGRMs).

Authors:  Andrew R Hudson; Steven L Roach; Robert I Higuchi
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

7.  Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.

Authors:  C A Findlay; J F Macdonald; A M Wallace; N Geddes; M D Donaldson
Journal:  BMJ       Date:  1998-09-12

Review 8.  Optimised glucocorticoid therapy: the sharpening of an old spear.

Authors:  Frank Buttgereit; Gerd-Rüdiger Burmester; Brian J Lipworth
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

Review 9.  Review: systemic absorption of topically applied ocular drugs in humans.

Authors:  L Salminen
Journal:  J Ocul Pharmacol       Date:  1990

10.  Adrenal suppression and growth retardation from ocular corticosteroids.

Authors:  J Steelman; M Kappy
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2001 May-Jun       Impact factor: 1.402

View more
  4 in total

1.  Linear growth arrest without weight gain due to overuse of topical clobetasol.

Authors:  Zahra Razavi; Milad Sanginabadi
Journal:  Oman Med J       Date:  2014-11

2.  Cushing syndrome after bilateral lensectomy.

Authors:  Karin Sofia Scherrer; Marcus Weitz; Johannes Eisenack; Béatrice Truffer; Daniel Konrad
Journal:  Eur J Pediatr       Date:  2014-12-24       Impact factor: 3.183

3.  Chronic Corticosterone Treatment During Adolescence Has Significant Effects on Metabolism and Skeletal Development in Male C57BL6/N Mice.

Authors:  Scott A Kinlein; Ziasmin Shahanoor; Russell D Romeo; Ilia N Karatsoreos
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

4.  Cushing Syndrome due to Inappropriate Corticosteroid Topical Treatment of Undiagnosed Scabies.

Authors:  Guadalupe Estrada-Chávez; Roberto Estrada; Daniel Engelman; Jesus Molina; Guadalupe Chávez-López
Journal:  Trop Med Infect Dis       Date:  2018-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.